Global and Japan Antiparasitic Drugs Market Size, Status and Forecast 2021-2027

SKU ID :QYR-19208612 | Published Date: 23-Sep-2021 | No. of pages: 124
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Antiparasitic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Anthelmintics 1.2.3 Antiprotozoals 1.2.4 Others 1.3 Market by Application 1.3.1 Global Antiparasitic Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Antiparasitic Drugs Market Perspective (2016-2027) 2.2 Antiparasitic Drugs Growth Trends by Regions 2.2.1 Antiparasitic Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Antiparasitic Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Antiparasitic Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Antiparasitic Drugs Industry Dynamic 2.3.1 Antiparasitic Drugs Market Trends 2.3.2 Antiparasitic Drugs Market Drivers 2.3.3 Antiparasitic Drugs Market Challenges 2.3.4 Antiparasitic Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Antiparasitic Drugs Players by Revenue 3.1.1 Global Top Antiparasitic Drugs Players by Revenue (2016-2021) 3.1.2 Global Antiparasitic Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Antiparasitic Drugs Revenue 3.4 Global Antiparasitic Drugs Market Concentration Ratio 3.4.1 Global Antiparasitic Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Antiparasitic Drugs Revenue in 2020 3.5 Antiparasitic Drugs Key Players Head office and Area Served 3.6 Key Players Antiparasitic Drugs Product Solution and Service 3.7 Date of Enter into Antiparasitic Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Antiparasitic Drugs Breakdown Data by Type 4.1 Global Antiparasitic Drugs Historic Market Size by Type (2016-2021) 4.2 Global Antiparasitic Drugs Forecasted Market Size by Type (2022-2027) 5 Antiparasitic Drugs Breakdown Data by Application 5.1 Global Antiparasitic Drugs Historic Market Size by Application (2016-2021) 5.2 Global Antiparasitic Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Antiparasitic Drugs Market Size (2016-2027) 6.2 North America Antiparasitic Drugs Market Size by Type 6.2.1 North America Antiparasitic Drugs Market Size by Type (2016-2021) 6.2.2 North America Antiparasitic Drugs Market Size by Type (2022-2027) 6.2.3 North America Antiparasitic Drugs Market Size by Type (2016-2027) 6.3 North America Antiparasitic Drugs Market Size by Application 6.3.1 North America Antiparasitic Drugs Market Size by Application (2016-2021) 6.3.2 North America Antiparasitic Drugs Market Size by Application (2022-2027) 6.3.3 North America Antiparasitic Drugs Market Size by Application (2016-2027) 6.4 North America Antiparasitic Drugs Market Size by Country 6.4.1 North America Antiparasitic Drugs Market Size by Country (2016-2021) 6.4.2 North America Antiparasitic Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Antiparasitic Drugs Market Size (2016-2027) 7.2 Europe Antiparasitic Drugs Market Size by Type 7.2.1 Europe Antiparasitic Drugs Market Size by Type (2016-2021) 7.2.2 Europe Antiparasitic Drugs Market Size by Type (2022-2027) 7.2.3 Europe Antiparasitic Drugs Market Size by Type (2016-2027) 7.3 Europe Antiparasitic Drugs Market Size by Application 7.3.1 Europe Antiparasitic Drugs Market Size by Application (2016-2021) 7.3.2 Europe Antiparasitic Drugs Market Size by Application (2022-2027) 7.3.3 Europe Antiparasitic Drugs Market Size by Application (2016-2027) 7.4 Europe Antiparasitic Drugs Market Size by Country 7.4.1 Europe Antiparasitic Drugs Market Size by Country (2016-2021) 7.4.2 Europe Antiparasitic Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Antiparasitic Drugs Market Size (2016-2027) 8.2 Asia-Pacific Antiparasitic Drugs Market Size by Type 8.2.1 Asia-Pacific Antiparasitic Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Antiparasitic Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Antiparasitic Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Antiparasitic Drugs Market Size by Application 8.3.1 Asia-Pacific Antiparasitic Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Antiparasitic Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Antiparasitic Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Antiparasitic Drugs Market Size by Region 8.4.1 Asia-Pacific Antiparasitic Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Antiparasitic Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Antiparasitic Drugs Market Size (2016-2027) 9.2 Latin America Antiparasitic Drugs Market Size by Type 9.2.1 Latin America Antiparasitic Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Antiparasitic Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Antiparasitic Drugs Market Size by Type (2016-2027) 9.3 Latin America Antiparasitic Drugs Market Size by Application 9.3.1 Latin America Antiparasitic Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Antiparasitic Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Antiparasitic Drugs Market Size by Application (2016-2027) 9.4 Latin America Antiparasitic Drugs Market Size by Country 9.4.1 Latin America Antiparasitic Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Antiparasitic Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Antiparasitic Drugs Market Size (2016-2027) 10.2 Middle East & Africa Antiparasitic Drugs Market Size by Type 10.2.1 Middle East & Africa Antiparasitic Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Antiparasitic Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Antiparasitic Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Antiparasitic Drugs Market Size by Application 10.3.1 Middle East & Africa Antiparasitic Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Antiparasitic Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Antiparasitic Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Antiparasitic Drugs Market Size by Country 10.4.1 Middle East & Africa Antiparasitic Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Antiparasitic Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Ipca Laboratories Ltd 11.1.1 Ipca Laboratories Ltd Company Details 11.1.2 Ipca Laboratories Ltd Business Overview 11.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Introduction 11.1.4 Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2016-2021) 11.1.5 Ipca Laboratories Ltd Recent Development 11.2 Zydus Cadila 11.2.1 Zydus Cadila Company Details 11.2.2 Zydus Cadila Business Overview 11.2.3 Zydus Cadila Antiparasitic Drugs Introduction 11.2.4 Zydus Cadila Revenue in Antiparasitic Drugs Business (2016-2021) 11.2.5 Zydus Cadila Recent Development 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Merck Business Overview 11.3.3 Merck Antiparasitic Drugs Introduction 11.3.4 Merck Revenue in Antiparasitic Drugs Business (2016-2021) 11.3.5 Merck Recent Development 11.4 Pfizer 11.4.1 Pfizer Company Details 11.4.2 Pfizer Business Overview 11.4.3 Pfizer Antiparasitic Drugs Introduction 11.4.4 Pfizer Revenue in Antiparasitic Drugs Business (2016-2021) 11.4.5 Pfizer Recent Development 11.5 GlaxoSmithKline Plc. 11.5.1 GlaxoSmithKline Plc. Company Details 11.5.2 GlaxoSmithKline Plc. Business Overview 11.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Introduction 11.5.4 GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2016-2021) 11.5.5 GlaxoSmithKline Plc. Recent Development 11.6 Cipla Ltd 11.6.1 Cipla Ltd Company Details 11.6.2 Cipla Ltd Business Overview 11.6.3 Cipla Ltd Antiparasitic Drugs Introduction 11.6.4 Cipla Ltd Revenue in Antiparasitic Drugs Business (2016-2021) 11.6.5 Cipla Ltd Recent Development 11.7 Ranbaxy Laboratories 11.7.1 Ranbaxy Laboratories Company Details 11.7.2 Ranbaxy Laboratories Business Overview 11.7.3 Ranbaxy Laboratories Antiparasitic Drugs Introduction 11.7.4 Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2016-2021) 11.7.5 Ranbaxy Laboratories Recent Development 11.8 Novartis AG 11.8.1 Novartis AG Company Details 11.8.2 Novartis AG Business Overview 11.8.3 Novartis AG Antiparasitic Drugs Introduction 11.8.4 Novartis AG Revenue in Antiparasitic Drugs Business (2016-2021) 11.8.5 Novartis AG Recent Development 11.9 Alvizia Health Care 11.9.1 Alvizia Health Care Company Details 11.9.2 Alvizia Health Care Business Overview 11.9.3 Alvizia Health Care Antiparasitic Drugs Introduction 11.9.4 Alvizia Health Care Revenue in Antiparasitic Drugs Business (2016-2021) 11.9.5 Alvizia Health Care Recent Development 11.10 Bayer AG 11.10.1 Bayer AG Company Details 11.10.2 Bayer AG Business Overview 11.10.3 Bayer AG Antiparasitic Drugs Introduction 11.10.4 Bayer AG Revenue in Antiparasitic Drugs Business (2016-2021) 11.10.5 Bayer AG Recent Development 11.11 Roche Inc 11.11.1 Roche Inc Company Details 11.11.2 Roche Inc Business Overview 11.11.3 Roche Inc Antiparasitic Drugs Introduction 11.11.4 Roche Inc Revenue in Antiparasitic Drugs Business (2016-2021) 11.11.5 Roche Inc Recent Development 11.12 Arbor Pharmaceuticals Inc. 11.12.1 Arbor Pharmaceuticals Inc. Company Details 11.12.2 Arbor Pharmaceuticals Inc. Business Overview 11.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Introduction 11.12.4 Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2016-2021) 11.12.5 Arbor Pharmaceuticals Inc. Recent Development 11.13 Sanofi 11.13.1 Sanofi Company Details 11.13.2 Sanofi Business Overview 11.13.3 Sanofi Antiparasitic Drugs Introduction 11.13.4 Sanofi Revenue in Antiparasitic Drugs Business (2016-2021) 11.13.5 Sanofi Recent Development 11.14 AstraZeneca 11.14.1 AstraZeneca Company Details 11.14.2 AstraZeneca Business Overview 11.14.3 AstraZeneca Antiparasitic Drugs Introduction 11.14.4 AstraZeneca Revenue in Antiparasitic Drugs Business (2016-2021) 11.14.5 AstraZeneca Recent Development 11.15 Alkem Laboratories Limited 11.15.1 Alkem Laboratories Limited Company Details 11.15.2 Alkem Laboratories Limited Business Overview 11.15.3 Alkem Laboratories Limited Antiparasitic Drugs Introduction 11.15.4 Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2016-2021) 11.15.5 Alkem Laboratories Limited Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Antiparasitic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Anthelmintics Table 3. Key Players of Antiprotozoals Table 4. Key Players of Others Table 5. Global Antiparasitic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Antiparasitic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Antiparasitic Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Antiparasitic Drugs Market Share by Regions (2016-2021) Table 9. Global Antiparasitic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Antiparasitic Drugs Market Share by Regions (2022-2027) Table 11. Antiparasitic Drugs Market Trends Table 12. Antiparasitic Drugs Market Drivers Table 13. Antiparasitic Drugs Market Challenges Table 14. Antiparasitic Drugs Market Restraints Table 15. Global Antiparasitic Drugs Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Antiparasitic Drugs Market Share by Players (2016-2021) Table 17. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiparasitic Drugs as of 2020) Table 18. Ranking of Global Top Antiparasitic Drugs Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Antiparasitic Drugs Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Antiparasitic Drugs Product Solution and Service Table 22. Date of Enter into Antiparasitic Drugs Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million) Table 25. Global Antiparasitic Drugs Revenue Market Share by Type (2016-2021) Table 26. Global Antiparasitic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Antiparasitic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Antiparasitic Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Antiparasitic Drugs Revenue Market Share by Application (2016-2021) Table 30. Global Antiparasitic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Antiparasitic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million) Table 33. North America Antiparasitic Drugs Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Antiparasitic Drugs Market Size by Application (2016-2021) (US$ Million) Table 35. North America Antiparasitic Drugs Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Antiparasitic Drugs Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Antiparasitic Drugs Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Antiparasitic Drugs Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Antiparasitic Drugs Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Antiparasitic Drugs Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Antiparasitic Drugs Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Antiparasitic Drugs Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Antiparasitic Drugs Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Antiparasitic Drugs Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Antiparasitic Drugs Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Antiparasitic Drugs Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Antiparasitic Drugs Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Antiparasitic Drugs Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Antiparasitic Drugs Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Antiparasitic Drugs Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Antiparasitic Drugs Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Antiparasitic Drugs Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Antiparasitic Drugs Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Antiparasitic Drugs Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Antiparasitic Drugs Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Antiparasitic Drugs Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Antiparasitic Drugs Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Antiparasitic Drugs Market Size by Country (2022-2027) & (US$ Million) Table 62. Ipca Laboratories Ltd Company Details Table 63. Ipca Laboratories Ltd Business Overview Table 64. Ipca Laboratories Ltd Antiparasitic Drugs Product Table 65. Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 66. Ipca Laboratories Ltd Recent Development Table 67. Zydus Cadila Company Details Table 68. Zydus Cadila Business Overview Table 69. Zydus Cadila Antiparasitic Drugs Product Table 70. Zydus Cadila Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 71. Zydus Cadila Recent Development Table 72. Merck Company Details Table 73. Merck Business Overview Table 74. Merck Antiparasitic Drugs Product Table 75. Merck Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 76. Merck Recent Development Table 77. Pfizer Company Details Table 78. Pfizer Business Overview Table 79. Pfizer Antiparasitic Drugs Product Table 80. Pfizer Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 81. Pfizer Recent Development Table 82. GlaxoSmithKline Plc. Company Details Table 83. GlaxoSmithKline Plc. Business Overview Table 84. GlaxoSmithKline Plc. Antiparasitic Drugs Product Table 85. GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 86. GlaxoSmithKline Plc. Recent Development Table 87. Cipla Ltd Company Details Table 88. Cipla Ltd Business Overview Table 89. Cipla Ltd Antiparasitic Drugs Product Table 90. Cipla Ltd Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 91. Cipla Ltd Recent Development Table 92. Ranbaxy Laboratories Company Details Table 93. Ranbaxy Laboratories Business Overview Table 94. Ranbaxy Laboratories Antiparasitic Drugs Product Table 95. Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 96. Ranbaxy Laboratories Recent Development Table 97. Novartis AG Company Details Table 98. Novartis AG Business Overview Table 99. Novartis AG Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 100. Novartis AG Recent Development Table 101. Alvizia Health Care Company Details Table 102. Alvizia Health Care Business Overview Table 103. Alvizia Health Care Antiparasitic Drugs Product Table 104. Alvizia Health Care Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 105. Alvizia Health Care Recent Development Table 106. Bayer AG Company Details Table 107. Bayer AG Business Overview Table 108. Bayer AG Antiparasitic Drugs Product Table 109. Bayer AG Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 110. Bayer AG Recent Development Table 111. Roche Inc Company Details Table 112. Roche Inc Business Overview Table 113. Roche Inc Antiparasitic Drugs Product Table 114. Roche Inc Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 115. Roche Inc Recent Development Table 116. Arbor Pharmaceuticals Inc. Company Details Table 117. Arbor Pharmaceuticals Inc. Business Overview Table 118. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product Table 119. Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 120. Arbor Pharmaceuticals Inc. Recent Development Table 121. Sanofi Company Details Table 122. Sanofi Business Overview Table 123. Sanofi Antiparasitic Drugs Product Table 124. Sanofi Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 125. Sanofi Recent Development Table 126. AstraZeneca Company Details Table 127. AstraZeneca Business Overview Table 128. AstraZeneca Antiparasitic Drugs Product Table 129. AstraZeneca Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 130. AstraZeneca Recent Development Table 131. Alkem Laboratories Limited Company Details Table 132. Alkem Laboratories Limited Business Overview Table 133. Alkem Laboratories Limited Antiparasitic Drugs Product Table 134. Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2016-2021) & (US$ Million) Table 135. Alkem Laboratories Limited Recent Development Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Global Antiparasitic Drugs Market Share by Type: 2020 VS 2027 Figure 2. Anthelmintics Features Figure 3. Antiprotozoals Features Figure 4. Others Features Figure 5. Global Antiparasitic Drugs Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Clinic Case Studies Figure 8. Others Case Studies Figure 9. Antiparasitic Drugs Report Years Considered Figure 10. Global Antiparasitic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Antiparasitic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Antiparasitic Drugs Market Share by Regions: 2020 VS 2027 Figure 13. Global Antiparasitic Drugs Market Share by Regions (2022-2027) Figure 14. Global Antiparasitic Drugs Market Share by Players in 2020 Figure 15. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiparasitic Drugs as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Antiparasitic Drugs Revenue in 2020 Figure 17. Global Antiparasitic Drugs Revenue Market Share by Type (2016-2021) Figure 18. Global Antiparasitic Drugs Revenue Market Share by Type (2022-2027) Figure 19. North America Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Antiparasitic Drugs Market Share by Type (2016-2027) Figure 21. North America Antiparasitic Drugs Market Share by Application (2016-2027) Figure 22. North America Antiparasitic Drugs Market Share by Country (2016-2027) Figure 23. United States Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Antiparasitic Drugs Market Share by Type (2016-2027) Figure 27. Europe Antiparasitic Drugs Market Share by Application (2016-2027) Figure 28. Europe Antiparasitic Drugs Market Share by Country (2016-2027) Figure 29. Germany Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Antiparasitic Drugs Market Share by Type (2016-2027) Figure 37. Asia-Pacific Antiparasitic Drugs Market Share by Application (2016-2027) Figure 38. Asia-Pacific Antiparasitic Drugs Market Share by Region (2016-2027) Figure 39. China Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Antiparasitic Drugs Market Share by Type (2016-2027) Figure 47. Latin America Antiparasitic Drugs Market Share by Application (2016-2027) Figure 48. Latin America Antiparasitic Drugs Market Share by Country (2016-2027) Figure 49. Mexico Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Antiparasitic Drugs Market Share by Type (2016-2027) Figure 53. Middle East & Africa Antiparasitic Drugs Market Share by Application (2016-2027) Figure 54. Middle East & Africa Antiparasitic Drugs Market Share by Country (2016-2027) Figure 55. Turkey Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Antiparasitic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Ipca Laboratories Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 59. Zydus Cadila Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 60. Merck Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 61. Pfizer Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 62. GlaxoSmithKline Plc. Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 63. Cipla Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 64. Ranbaxy Laboratories Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 65. Novartis AG Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 66. Alvizia Health Care Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 67. Bayer AG Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 68. Roche Inc Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 69. Arbor Pharmaceuticals Inc. Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 70. Sanofi Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 71. AstraZeneca Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 72. Alkem Laboratories Limited Revenue Growth Rate in Antiparasitic Drugs Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed
Ipca Laboratories Ltd Zydus Cadila Merck Pfizer GlaxoSmithKline Plc. Cipla Ltd Ranbaxy Laboratories Novartis AG Alvizia Health Care Bayer AG Roche Inc Arbor Pharmaceuticals Inc. Sanofi AstraZeneca Alkem Laboratories Limited
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients